New gut bacteria therapy tested for colitis
NCT ID NCT06582264
First seen Feb 18, 2026 · Last updated May 22, 2026 · Updated 16 times
Summary
This early-stage study tested a new treatment called MB310 in 29 adults with mild-to-moderate ulcerative colitis. The main goal was to see if it is safe and how well it settles in the gut. Participants received either MB310 or a placebo, and researchers monitored side effects and signs of disease control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Acibadem City Clinic, Tokuda Hospital
Sofia, Bulgaria
-
Addenbrooke's Hospital
Cambridge, United Kingdom
-
Centrum Medyczne Kermed
Bydgoszcz, Poland
-
Diagnostic Consulting Center Convex EOOD
Sofia, Bulgaria
-
Diagnostic-Consulting Center
Varna, Bulgaria
-
Klinikum Klagenfurt am Woerthersee
Klagenfurt, Austria
-
Korczowski Bartosz, Gabinet Lekarski
Rzeszów, Poland
-
Medical Center Rusemed EOOD
Sofia, Bulgaria
-
Medizinische Universitaet Innsbruck
Innsbruck, Austria
-
Medizinische Universitaet Wien
Vienna, Austria
-
Panstwowy Instytut Medyczny MSWiA - Klinika Gastroenterologi i Chorob Wewnetrznych
Warsaw, Poland
-
Royal Victoria Infirmary
Newcastle, United Kingdom
-
St George's Hospital
London, United Kingdom
-
Uniklinikum Salzburg
Salzburg, Austria
-
University Hospital Birmingham
Birmingham, United Kingdom
-
University Multiprofile Hospital for Active Treatment
Stara Zagora, Bulgaria
-
Warsaw IBD Point
Warsaw, Poland
-
Wojskowy Instytut Medyczny - Panstwowy Instytut Badawczy, Klinika Gastroenterologii i Chorob Wewnetrznych
Warsaw, Poland
Conditions
Explore the condition pages connected to this study.